National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1962. No. 101.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1961.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1961.

Dated this  thirteenth

day of  October  1962.

DE L'ISLE

Governor-General.

By His Excellency's Command,

(SGD.) H.W. WADE

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits)

Regulations.  

Commencement.

1. These Regulations shall come into operation on the first day of November, 1962.

First, Second, Third, Fourth, and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

First Schedule.

Regulation 10.

DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.

Absorbable Gelatin Sponge.

Acetazolamide.

Acetomenaphthone.

Adrenaline Acid Tartrate.

Alcohol.

Amethocaine Hydrochloride.

Amethocaine Injection.

Amodiaquine Hydrochloride.

Amphetamine.

Amphetamine Sulphate.

Amylobarbitone.

Amylobarbitone Sodium.

Amylobarbitone Sodium Tablets.

Antimony Potassium Tartrate.

*Notified in the Commonwealth Gazette on 31 October 1962.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; and 1962, No. 34.

8055/62.—Price1s. 10/10.10.1962.

First Schedule—continued.

Antimony Sodium Tartrate.

Antimony Sodium Tartrate Injection.

Apomorphine Hydrochloride.

Apomorphine Injection.

Azovan Blue.

Bacillus Calmette-Guerin Vaccine.

Bacitracin.

Bemegride.

Benzhexol Hydrochloride.

Bismuth Oxychloride.

Bismuth Oxychloride Injection.

Bismuth Sodium Tartrate.

Busulphan.

Butobarbitone.

Calciferol.

Camphor Water.

Caraway.

Carbachol.

Carbimazole.

Carbon Dioxide.

Cardamom Fruit.

Catgut, sterilized surgical.

Cellulose Oxidized.

Chlorcyclizine Hydrochloride.

Chorionic Gonadotropin.

Chloroquine Phosphate.

Chloroquine Sulphate.

Chlorothiazide.

Chloroxylenol.

Chlortetracycline Injection.

Cinchocaine Hydrochloride.

Cinnamon.

Cochineal.

Cod Liver Oil.

Colchicine.

Colchicum Corm.

Coriander.

Corticotrophin.

Cresol.

Cyanocobalamin.

Cyclobarbitone.

Cyclopropane.

Dapsone.

Dexamphetamine Sulphate.

Dextran Injection.

Dextran Sulphate.

Dextran Sulphate Injection.

Dick Control.

Dick Test Toxin.

Diethylcarbamazine Citrate.

Digitalis Leaf.

Dimercaprol.

Diodone Injection.

Diphtheria and Pertussis Vaccine.

Dithranol.

Emetine and Bismuth Iodide.

Emetine Hydrochloride.

Ergometrine Maleate.

Ether Vinyl.

Ethinyloestradiol.

Ethisterone.

Ethopropazine Hydrochloride.

Ethyl Biscoumacetate.

Ethyl Chloride.

Ethylenediamine Hydrate.

Ethyl Oleate.

Gallamine Triethiodide.

Gallamine Injection.

Gentian.

Gentian Compound Infusion.

Ginger.

Halothane.

Hamamelis.

Helium.

Heparin.

Hexamethonium Tartrate.

Histamine Acid Phosphate.

Human Blood, whole.

Human Red Blood Corpuscles, concentrated.

Human Fibrin Foam.

Human Fibrinogen.

Human Gamma Globulin.

Human Gamma Globulin Injection.

Human Serum, dried.

Human Serum, liquid.

Human Plasma, dried.

Human Thrombin.

Hydrocortisone Acetate Ointment.

Hydrocortisone Hydrogen Succinate.

Hydrocortisone Ointment.

Hydrogen Peroxide Solution, strong.

Hydroxychloroquine Sulphate.

Hyoscine Eye Ointment.

Hyoscyamus.

Indigo Carmine.

Iodised Oil Injection.

Iodoxyl.

Iopanoic Acid.

Iopanoic Acid Tablets.

Ipecacuanha.

Ipecacuanha, prepared.

Isoniazid.

Lead Acetate.

Lead Monoxide.

Lemon Peel, dried.

Lemon Peel, fresh.

Leptazol.

Lignocaine and Adrenaline Injection.

Lignocaine Hydrochloride.

Lignocaine Hydrochloride Injection.

Liothyronine Sodium.

Liothyronine Tablets.

Lucanthone Hydrochloride.

Male Fern.

Male Fern Extract.

Maleic Acid.

Mannitol.

Mepacrine Hydrochloride.

Mephenesin.

Mephenesin Injection.

Mercaptofurine.

Mercuric Oxide, yellow.

Mercury.

Mersalyl Acid.

Methadone Hydrochloride.

First Schedule—continued.

Methoin.

Methyltestoserone.

Methylamphetamine Hydrochloride.

Methylthiouracil.

Mustine Hydrochloride.

Nalorphine Hydrobromide.

Naphazoline Hydrochloride.

Neostigmine Bromide.

Neostigmine Methylsulphate.

Nicotinic Acid.

Nikethamide.

Nitrous Oxide.

Nux Vomica.

Oestradiol Benzoate.

Opium.

Opium, powdered.

Orange Peel, dried bitter.

Orange Peel, fresh bitter.

Ouabain.

Oxygen.

Oxytetracycline Dihydrate.

Paramethadione.

Pentamidine Injection.

Pentamidine Isethionate.

Pethidine Tablets.

Phenindamine Tartrate.

Phenindione.

Pheniodol.

Phenolphthalein Tablets.

Phenolsulphonphthalein.

Phytomenadione.

Phytomenadione Capsules.

Picrotoxin.

Poliomyelitis Vaccine.

Potassium Perchlorate.

Prednisone Acetate.

Primaquine Phosphate.

Primidone.

Probenecid.

Procyclidine Hydrochloride.

Procaine and Adrenaline Injection,

Progesterone.

Proguanil Hydrochloride.

Propyliodone.

Propyliodone Injection.

Propyliodone Oily Injection.

Propyl Thirouracil

Pyridostigmine Bromide.

Pyrimethamine.

Pyrimethamine Tablets.

Quillaia.

Senna Leaf.

Sesame Oil.

Soda Lime.

Sodium Aminosalicylate Tablets.

Sodium Antimonylgluconate.

Sodium Antimonylgluconate Injection.

Sodium Aurothiomalate.

Sodium Radio-iodido (181 I) Injection.

Sodium. Radio-iodido (181 I) Solution.

Sodium. Radiophosphate (88 P) Injection.

Sodium Radiophosphate (82 P) Solution.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Solapsone.

Solapsono Tablets.

Stibophen.

Stramonium Dry Extract.

Sulphadimidine Sodium.

Suramin.

Suxamethonium Bromide.

Suxamethonium Chloride.

Suxamethonium Chloride Injection.

Testosterone.

Tetrachloroethylene.

Thiomersal.

Thiopentone Sodium.

Thiopentone Injection.

Thyroid.

Thyroxine Sodium.

Tolazoline Hydrochloride.

Tolbutamide.

Trichloroethylene.

Tryparsamide.

Tuberculin, old.

Tuberculin Purified Protein Derivative.

Tubocurarine Chloride.

Tubocurarine Injection.

Typhoid-Paratyphoid A and B and Cholera Vaccine.

Typhoid-Paratyphoid A and B tetanus Vaccine.

Yellow Fever Vaccine.

Second Schedule.

Regulation 10(3).

DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Dried Aluminium Hydroxide Gel. B.P...........	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Dried Aluminium Hydroxide Gel. B.P. with Magnesium Carbonate B.P.
Aluminium Hydroxide Gel. B.P....................	Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P.
Aluminium Hydroxide Gel. B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.
Aluminium Hydroxide Gel. B.P. with Kaolin Light B.P. and Pectin
Aluminium Hydroxide Gel. B.P. with Magnesium Hydroxide
Aluminium Hydroxide Gel. with Magnesium Trisilicate B.P.
Aluminium Powder .....................................	Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P.
Amiphenazole Hydrobromide ......................	—
Amiphenazole Hydrochloride A.P.F. 1955	—
Aneurine Hydrochloride B.P. .......................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Ascorbic Acid B.P. ......................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Bendrofluazide ............................................	—
Benethamine Penicillin ................................	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Benzalkomum Chloride ...............................	—
Benzathine Penicillin B.P. ...........................	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin B.P. ...................................	Fortified Procaine Penicillin Injection B.P.
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin Sodium B.P........................	Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P.
Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Betamethasone Phosphate ............................	—
Bismuth Subnitrate B.P.C. ...........................	Resorcinol B.P. with Bismuth Subnitrate B.P.C. Zinc Oxide B.P., Starch B.P., Cade Oil B.P. Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P.
Butabarbital Sodium....................................	—
Carbromal B.P.............................................	Pentobarbitone Sodium B.P. with Carbromal B.P.
Chloramphenicol B.P. .................................	Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water
Chloramphenicol B.P. with Propylene Glycol B.P.
Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Chlorhexidine Diacetale...............................	—
Chlorpromazine Hydrochloride B.P. .............	—
Chlortetracycline Calcium ...........................	—
Chlortetrycline Hydrochloride B.P. ..............	Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Clemizole ...................................................	—
Cortisone Acetate B.P. ................................	—
Demethylchlortetracycline Hydrochloride.....	—
Dexamethasone Sodium Phosphate ..............	—
Dextrochlorpheniramine Maleate .................	—
Dicyclomine Hydrochloride .........................	—
Dienoestrol B.P. ..........................................	—
Diethyl Dithiolisophthalate ..........................	—
Diiodohydroxyquinoline B.P. .......................	—
Diphtheria Vaccine B.P. ..............................	Diphtheria, Tetanus and Pertussis Vaccine B.P. Diphtheria and Tetanus Vaccine B.P.
Diphtheria and Tetanus Vaccine B.P ............	—
Ergotamine Tartrate B.P. .............................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin B.P. .......................................	—
Ethotoin ......................................................	—
Ferrous Aminoacetosulphate ........................	—
Ferrous Succinate ........................................	—
Glucose Indicator ........................................	—
Gramicidin .................................................	Gramicidin with Polymyxin B. Sulphate B.P. and Neomycin Sulphate B.P.
Griscofulvin ................................................	—
Guanethidine Sodium ..................................	—
Haemophilus Influenza Bacterial Serum........	—
Hamamclis Dry Extract ...............................	Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P.
Hexocyclium Methyl Sulphate .....................	—
Hydrocortisone B.P. ....................................	—
Hydrocortisone Acetate B.P. ........................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Hydrocortisone Sodium Succinate ................	—
Isoprenaline Hydrochloride ..........................	—
Isopropamide Iodide ....................................	—
Levallorphan Tartrate .................................. ..	Levallorphan Tartrate with Pethidine Hydrochloride B.P.
Lofenalac ...................................................	—
Meclozine Hydrochloride B.P.C. ..................	—
Mercuric Oxide Eye Ointment B.P................	—
Methazolamide ...........................................	—
Methscopolamine Bromide ..........................	—
Methyclothiazide ........................................	—
Methylphenobarbitone B.P.C. ......................	—
Methylprednisolone .....................................	—
Minafen ......................................................	—
Naphazoline Nitrate B.P. .............................	Antazoline Hydrocloride B.P. with Naphazoline Nitrate B.P.
Neomycin Sulphate B.P., Eye Drops ............	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Neomycin Sulphate B.P. with Polymyxin B. Sulphate B.P. and Gramicidin

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Nicotinamide B.P.........................................	Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Oestrone .....................................................	—
Oleandomycin .............................................	Tetracycline with Oleandomycin
Oleoresin Capsicum ....................................	Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum
Oxyphencyclimine Hydrochloride ................	—
Oxyphenonium Bromide ..............................	—
Oxytetracycline Hydrochloride B.P. .............	Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Papaveretum B.P.C. ....................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Pancreatin B.P. ...........................................	—
Pempidine Tartrate ......................................	—
Pentolinium Tartrate B.P. ............................	Pentolinium Tartrate B.P. with Ephedrine B.P.
Pethidiue Hydrochloride B.P. .......................	Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P.
Pethidine Hydrochloride B.P. with Levallorphan Tartrate
Pertussis Vaccine B.P. .................................	Diphtheria, Tetanus and Pertussis Vaccine B.P. Diphtheria and Pertussis Vaccine B.P.
Phenoxymethylpenicillin B.P. ......................	—
Phenoxymethylpenicillin (Benzathine Salt)....	—
Phenoxymethylpenicillin Calcium B.P..........	—
Phenoxymethylpenicillin (Hydrabamine Salt)	—
Phenoxymethylpenicillin Potassium B.P........	—
Pipenzolatc .................................................	—
Polydimethylsiloxanes .................................	—
Polymyxin B. Sulphate B.P. .........................	Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer
Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P.
Polymyxin B. Sulphate B.P. with Tetracycline Hydrochloride
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Prednisolone B.P. ........................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. R.P.
Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Prednisolone Disodium Phosphate ................	—
Prednisone B.P. ...........................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Procaine Hydrochloride B.P. ........................	Procaine Hydrochloride B.P. in Normal Saline Tetracycline and Procaine Injection B.P.
Pyrazinamide ..............................................	—
Pyridine Aldozime Methiodide ....................	—
Pyrimido-Pyrimidine ...................................	—
Pyrrolidino-Mcthyl-Tetracycline ..................	—

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Rauwolfia Alkaloids ....................................	—
Reserpine B.P. ............................................	—
Riboflavine B.P. ..........................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Sobee .........................................................	—
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydratcd Calcium Chloride B.P. in Water for Injection B.P.............................	Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P.
Compound Sodium Lactate Injection B.P......	Compound Sodium Lactate Injection B.P. with Dextrose B.P.
Sodium Lauryl Sulphate B.P. .......................	Emulsifying Wax B.P.
Streptomycin Sulphate B.P. .........................	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P.
Streptomycin Sulphate B.P., with Normal Saline
Sulphadimidine B.P. ....................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphamerazine B.P.....................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulnhacetamide
Sulphacetamide ...........................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphathiazole ............................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Tacrine .......................................................	Tacrine with Morphine
Terpineol B.P. .............................................	Solution of Chloroxylenol B.P.
Tetanus Vaccine B.P. ..................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride B.P. ..................	Tetracycline Hydrochloride B.P. with Nystatin
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Tetracycline ................................................	Tetracycline with Oleandomycin
Thenalidine .................................................	Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobroma Prepared B.P.C. .........................	Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C.
Triamcinolone .............................................	—
Trifluoperazine ...........................................	—
Tricyclamol Chloride ..................................	—
Tripelennamine Hydrochloride .....................	—
Troxidone B.P. ............................................	—
Typhoid Para-Typhoid A and B Vaccine B.P.	Typhoid Para-Typhoid A, B and C Vaccine B.P.
Viprynium Embonate ..................................	—
Concentrated Vitamin A Solution B.P...........	Concentrated Vitamins A and D Solution B.P.
Concentrated Vitamin D Solution B.P...........	Concentrated Vitamins A and D Solution B.P.
Vitamin D ...................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Yellow Mercuric Oxide B.P. ........................	Mercuric Oxide Eye Ointment B.P.

Third Schedule.

Regulation 11.

PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPEIA.

Acetazolamide Sodium.

Acetyl-Sulphamethoxypridazine.

Aconite Liniment, B.P.C.

Acriflavine, B.P. 1948.

Acrylic Resin.

Adrenaline Hydrochloride Solution, B.P. 1953.

Adrenaline Mucate.

Agar, B.P.C.

Aloes Pill, B.P. 1948.

Aloin, B.P. 1953.

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Powder.

Amaranth Solution, A.P.F.

Amaranth Solution, B.P.C. 1954

Amidopyrin, B.P.C. 1954.

Amiphenazole Hydrobromide.

Amiphenazole Hydrochloride, A.P.F. 1955.

Ammonium Acetate, Strong Solution, B.P. 1953.

Ammonium Bicarbonate, B.P. 1953.

Ammonium Bromide, B.P.C.

Amphotericin B.

Androstanolone.

Aniseed Water, concentrated, B.P.C.

Aniseed Spirit, B.P.C. 1949.

Aromatic Ammonia Spirit, B.P. 1953.

Aurothioglucose.

Balsam of Peru, B.P.C.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Bendrofluazide.

Benzalkonium Chloride.

Benzoinated Lard, B.P.C. 1954.

Benzol (Commercial).

Benzylpenicillin in Oil.

Bephenium Hydroxynaphthoate.

Betamethasone.

Betamethasone Phosphate.

Bismuth Carbonate, B.P. 1953.

Bismuth Glycollylarsanilate.

Bismuth Subgallate, B.P.C.

Bismuth Subnitrate, B.P.C.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu Concentrated Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Caffeine Citrate, B.P.C.

Cajuput Spirit, B.P. 1948.

Calamine Cream, A.P.F.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium Aminosalicylate, B.P.C.

Calcium Phosphate, B.P. 1953.

Caluma Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Camphor Water, concentrated, B.P.C. 1949.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Caramiphen Hydrochloride.

Caraway Oil, B.P.C.

Carbinoxamine Maleate.

Cardamom Aromatic Tincture, B.P.C.

Carmine Solution, A.P.F.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Charcoal.

Chlorambucil.

Chloramine, B.P.C.

Chlorazanil.

Chlorhexidine Diacctate.

Chlormerodrin.

Chlorobenzol Disulphonamide.

Chloroform Water, concentrated, B.P.C.

Chlorpheniramine Maleate.

Chlorpropamide.

Chlortetracyline Calcium.

Chlorthalidone.

Spirit of Cinnamon, B.P.C. 1949.

Clemizole Hydrochloride.

Clemizole Tannate Syrup.

Cloves, Concentrated Infusion, B.P.C. 1954.

Cochineal Tincture, 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Cod Liver Oil Emulsion, B.P., 1953.

Colchicine Salicylate.

Colocynth and Hyoscyamus Pill, B.P.C.

Colocynth, B.P.C.

Compound Effervescent Powder, B.P. 1953.

Creosote, B.P. 1953.

Crude Coal Tar.

Cudbear Tincture, A.P.F. 1947.

Cyclopenthiazide.

Cyclophosphamide.

Cycloserine.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine.

Darrow's Solution.

Death Adder Antivenene.

Demecarium Bromide.

Demethylchlortctracycline Hydrochloride.

Desacetyl-Lanatoside, C.

Dexamethasone.

Dexametliasone Sodium Phosphate.

Dextran Iron.

Dextrin Iron.

Dextrochlorpheniramine Maleate.

Dichlorphenamide.

Dicyclomine Hydrochloride.

Diethazine Hydrochloride.

Diethyl Dithiolisophthalate.

Third Schedule—continued.

Diloxanide Furoate.

Digitoxin, B.P.C.

Dihydroergotamine.

Dihydromorphinone Hydrochloride, B.P.C. 1949.

Diphenylpyraline Hydrochloride.

Diphtheria Toxoid Purified.

Disodium Diethylstilboestrol Diphosphate.

Disodium Dihydrogen Versenate.

Dithiazanine Iodide.

Dyflos, B.P.C.

Ecothiopate Iodide.

Ephedrine Sulphate, B.P.C. 1954.

Ergot Liquid Extract, B.P.C. 1954.

Erythrityltetranitrate, B.P.C. 1949.

Erythromycin Glucoheptonate.

Erythromycin Propionate.

Erythromycin Stearate.

Ethionamide.

Ethosuximide.

Ethotoin.

Ethoxzolamide.

Etlylidene Dicoumarin.

Ethylnoradrenaline.

Ferric Hydroxide.

Ferric Chloride Solution, B.P.C.

Ferrous Aminoacetosulphate.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Fludrocortisone Acetate.

Fluoxymesterone.

Formyl-Tetrahydropteroyl Glutamic Acid.

Fructose, B.P. 1948.

Gall with Opium Ointment, B.P.C.

Gelsemium Tintcure, B.P.C.

Gentian Violet.

Glucagon Hydrochloride.

Glucose Indicator.

Glucose Liquid, B.P. 1953.

Glutethimide, B.P.C.

Glycerophosphates Compound Syrup, A.P.F.

Gramicidin.

Griseofulvin.

Guanethidine Sodium.

Guanethidine Sulphate.

Haemophilus Influenza Bacterial Serum.

Hamamelis Dry Extract.

Heparin Retard.

Hexachlorophene, 3% with Entsufon.

Hexachlorophene, 3% with Lissapol.

Hexachlorophene, 1.5% with Soap Solution.

Hexachlorothiazide.

Hexocyclium Methyl Sulphate.

Hexoestrol.

Honey, Purified, B.P.C.

Hydrocalciferol.

Hydrocyanic Acid Dilute, B.P.C. 1954.

Hydroflumethiazide.

Hypophosphorous Acid Dilute, B.P.C.

Insulin Isophone (N.P.H.).

Insulin Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform B.P.C.

Iodoform Suppository, B.P. 1948.

Ipomoca Rosin.

Iron Aminote.

Iron Carbonate Saccharated, B.P.C.

Iron Oxide Saccharated.

Iron Carbohydrate Complex.

Iron Phosphate Compound Syrup, B.P.C.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Isothipendyl Hydrochloride.

Kanamycin Sulphate.

Lavender Oil, Spike, B.P.C.

Lemon Syrup, neutral, A.P.F.

Levallorphan Tartrate.

Levorphanol Tartrate, B.P.C.

Lissapol, N 100.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Mebhydrolin.

Mecamylamine.

Mecholyl Chloride.

Meclozine Hydrochloride, B.P.C.

Mephentermine Sulphate.

Mercaptomerin Sodium.

Mercuric Chloride, B.P. 1953.

Mercurous Chloride Ointment, B.P. 1948.

Mercury Compound Ointment, B.P.C.

Methazolamide.

Methenamine Mandelate.

Methenolone Oenanthate.

Methicillin.

Methotrexate.

Methscopolamine Bromide.

Methyclothiazide.

Methyl Androstanolone.

Methyl Atropine Nitrate.

Methylcellulose, A.P.F.

Methylcellulose Mucilage, A.P.F.

Methyl Prednisolone.

Methyl Prednisolone Acetate.

Methylandrostenediol.

Methylphenobarbitone, B.P.C.

Metronidazole.

Minafen.

Myrrh, B.P.C.

Myrrh Tincture, B.P.C.

Nandrolone.

Nicoumalone.

Nitrofurantoin.

Nitromin.

Nitrous Ether Spirit, B.P.C.

Norethandrolone

Nux Vomica Extract, Dried, B.P. 1953.

Nystatin.

Oestradiol Dipropionate.

Oestrone.

Third Schedule—continued.

Oleandomycin.

Oleoresin Capsicum.

Orange Peel Infusion Concentrated, B.P. 1948.

Orange Peel Infusion Concentrated, Compound, B.P.C.

Ox-Bile Extract, B.P. 1948.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Pancreatin 4, U.S.N.F. XI.

Para-Aminosalicyclic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F.

Paraben Ophthalmic, Vehicle, A.P.F.

Paracetamol.

Paramethasone Acetate.

Papaveretum, B.P.C.

Pectin.

Pempidine Tartrate.

Penicillin Benethamine.

Penicillinase.

Pentaerythritol Tetranitrate.

Penthienate.

Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed).

Phenazone, B.P.C.

Phenazopyradine Hydrochloride.

Phenethicillin.

Phenformin.

Phenoxymethylpenicillin (Benzathine Salt).

Phenoxymethylpenicillin (Hydrabamine Salt).

Phensuximide.

Phenylbutazone.

Phenylmercuric Dinaphthylmethane Disulphonate.

Phenytoin.

Pholcodine, B.P.C.

Pholcodine Citrate Syrup, B P C.

Phthalylsulphacetamide.

Physostigmine Alkaloid.

Pipenzolate.

Pituitary (Posterior Lobe).

Polydimethylsiloxanes.

Potash Sulphurated, B.P.C.

Potassium Chlorate, B.P.C.

Prednisolone Disodium Phosphate.

Prednisolone Sodium Hemisuccinate.

Prednisolone Trimethylacetate.

Prophenpyridamine Maleate.

Prophenpyridamine Para-Aminosalicylate.

Propylthiouracil B.P.C.

Protamine Sulphate.

Protoveratrines A.

Pyrazinamide.

Pyridine Aldoxine Methiodide.

Pyrrolidino-Methyl-Tetracycline.

Quillaia Tincture, B.P.C.

Rauwolfia Alkaloids.

Red Back Spider Antivenene.

Red Syrup.

Ristocetin.

Salicylamide.

Salicylazosulphapyridine.

Senega Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C.

Senna Fruit Extract.

Senna Loaf Concentrated Infusion, B.P.C.

Siberian Fir Oil, B.P.C. 1949.

Silver Picrate, B.P.C. 1949.

Silver Protein Mild, B.P.C.

Soap Curd, B.P.C.

Soap, Hard, B.P.C.

Sobee.

Sodium Calcium Edetate.

Sodium Carbonate Exsiccated, B.P.C.

Sodium Folate.

Sodium Lactate.

Sodium Nitrite, B.P.C.

Sodium Olcate Acid.

Sodium Tauroglycocholate.

Sorbolene, A.P.F.

Spearmint Oil.

Spiramycin.

Spironolactone.

Squill Syrup, B.P.C.

Squill Tincture.

Squill Vinegar, B.P. 1948.

Stearic Acid, B.P.C.

Strophantus Tincture, B.P. 1948.

Strychnine, B.P.C.

Sulfinpyrazone.

Sulphacetamide.

Sulphadiazine Sodium.

Sulphadimethoxine.

Sulphamethoxydiazine.

Sulphamethoxypyridazine.

Sulphafurazole.

Sulphamethizole.

Sulphaphenazole.

Sulphathiazole.

Sulphapyridine, B.P.C.

Sulphuric Acid Dilute, B.P.C.

Surgical Cement.

Sustanon.

Syntocinon.

Tacrine.

Taipan Antivenene.

Talc Purified, B.P.C.

Testosterone Oenanthate.

Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.

Tetracycline.

Thenalidine Tartrate.

Theobromine, B.P.C.

Theobroma Prepared, B.P.C.

Thiacotazone.

Thiambutosine.

Thyrotrophin.

Tiger Snake Antivenene.

Tretainino.

Triamcinolone.

Third Schedule—continued.

Tricyclamol Chloride.

Triethanolamine, B.P.C.

Triethanolamine Trinitrate.

Triethylene Thiophosphoramide.

Trifluoperazine.

Trimetaphan Camphorsulphonate.

Trinitorphenol, B.P.C.

Triprolidine

 Hydrochloride.

Valerian Ammoniated Tincture, B.P.C.

Vancomycin Hydrochloride.

Vasopressin Tannate in Oil.

Veriloid.

Viomycin Sulphate.

Viprynium Embonate.

Vitamin A.

Vitamin D.

Vitamin K.

Volatile Bitter Almond Oil, B.P. 1953.

Warfarin Sodium.

Fourth Schedule.

Regulation 12.

ADDITIVES.

Acetone, B.P.C.

Alcohol, B.P.

Amethocaine Hydrochloride, B.P.

Bacitracin, B.P.

Carmine Solution, A.P.F.

Cod Liver Oil, B.P.

Oil of Caraway, B.P.C.

Oil of Citronella, B.P.C.

Xylene, B.P.C. 1949.

Fifth Schedule.

Regulation 14.

PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.

 

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Acrylic Resin ..............................................	Ileostomy or colostomy conditions
Amiphenazole Hydrobromide..................	As an antidote to barbiturate and other hypnotic poisons
Amiphenazole Hydrochloride A.P.F. 1955...................................................
Amphotericin B ...........................................	Systemic fungal infections
Androstanolone ...........................................	Mammary carcinoma
Aneurine Hydrochloride Tablets B.P.............	Any disease or condition in a pensioner
Ascorbic Acid Tablets B.P. ..........................	Any disease or condition in a pensioner
Bemegride Injection B.P...............................	As an antidote to barbiturate and other hypnotic poisons
Benzol (Commercial) ..................................	Ileostomy or colostomy conditions
Betamethasone ............................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
		Busulphan Tablets B.P. ...............................	The leukaemias
Calciferol Tablets B.P..................................	Any disease or condition in a pensioner
With the written authority of the Director-General, idiopathic hypoparathyroidism
	Calciferol Solution B.P.................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Para-Aminosalicylatc B.P.C............	Tuberculosis
Caramiphen Hydrochloride ..........................	Parkinsonism
Chlorambucil ..............................................	Malignant lymphoma and related conditions
Chloraminc B.P.C., Tablets or Powder	Ileostomy or colostomy conditions
Chloramphenicol Capsules B.P. ...................	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
Bacterium coli meningitis, if other forms of treatment are unsuccessful
Brucellosis
Granuloma inguinale
Friedlander bacillus infections
Haemophilus influenza infections
Laryngo-trachco-bronchitis, acute
Lymphogranuloma venereum
Pre-operative prophylaxis
Salmonella infections
Staphylococcal infections
Surgical conditions of the bowel (pre-operative and post-operative)
Typhoid fever
Typhus and other rickettsial diseases
Urinary tract infections duo to gram negative bacilli that arc resistant to the Sulphonamides
Whooping cough (Haemophilus pertussis)
As an alternative to the Penicillins in a person sensitive to the Penicillins
Severe gastro-enteritis in a child under the age of sixteen years
Chloramphenicol B.P., Injection...................	A disease or condition specified in this column in relation to Chloramphenicol Capsules

Fifth Schedule—continued.

 

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Chloramphenicol B.P., Oral Suspension........	A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years
Chlorpheniramine Maleate Oral Linctus........	Any disease or condition in a child under the age of twelve years
Chlorpromazine Hydrochloride B.P. .............	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride or Trifluoperazine
Chlortetracycline Capsules B.P. ...................	As an alternative to the Penicillins in a person sensitive to the Penicillins
Actinomycosis
Amoebiasis
Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute
Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
Bronchiectasis
Brucellosis
Chancroid
Fibrocystic disease of the pancreas
Granuloma inguinale
Friedlander bacillus infections
Leptospirosis
Lymphogranuloma venereum
Mucoviscidosis
Pneumonia that is resistant both to the Penicillins and the Sulphonamides
Pre-operative prophylaxis
Primary atypical pneumonia
Psittacosis
Puerperal infections
Rat-bite fever (Spirillum minus)
Staphylococcal infections
Trachoma that is resistant to the Sulphonamides
Typhus and other rickettsial diseases
Urinary tract infections duo to gram negative bacilli that are resistant to the Sulphonamides
Whooping cough (Haemophilus pertussis)
Chlortetracycline Calcium .......................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Chlortetracycline B.P. Granules...............

Fifth Schedule—continued.

 

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Clemizole Tannate Syrup .............................	Any disease or condition in a child under the age of twelve years
Cod Liver Oil, B.P................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Cod Liver Oil Emulsion B.P. 1953........
Corticotrphin Injection B.P...........................	With the written authority of the Director-General—
Corticotrophin Gelatin Injection B.P.......	A disease or condition specified in this column in relation to Cortisone Injection
Cortitrophin Zinc Hydroxide Injection B.P...........................................................	The treatment of side effects of corticosteroid therapy
		Cortisone Injection B.P. ...............................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Addison's disease and other forms of adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Cranial arteritis
Cushing's syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliotive, associated with drug therapy
Dermatomyositis
Encephalomyelitis
Guillain-Barre syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen's disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin's disease
Idiopathic hypercalcaemia
Keratoplasty
The leukaemias
Lymphosarcoma and follicular lymphoma
Metastatic breast carcinoma
Nephritis, type II.
Nephrosis or nephrotic syndrome
Neuro-myelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch's
Purpura, thrombocytopenic
Reticulum cell sarcoma
Rheumatic carditis, acute
Salaam convulsions and hypsarrythmia
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia and agranulocytosis
Status asthmaticus

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still's disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Ulcerative colitis proven by sigmoidoscopy or radiological report
Uveitis, posterior
Cortisone Tablets B.P. .................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength).............................	Established megalocytic anaemias
Cyanocobalamin Injection B.P., 1,000 microgrammc strength	Neuroblastoma
Cymogran ...................................................	With the written authority of the Director-General, phenylketonuria
Cycloserine .................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Demethylchlortetracycline Hydrochloride.....	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Deoxycortone Acetate B.P. .....................
Deoxycortone Acetate Injection B.P.........	Addison's disease
Deoxycortone Acetate Implant B.P...........	Total adrenalectomy
Dexamcthasone ...........................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Dextrochlory heniramine Maleate Syrup.......	Any disease or condition in a child under the age of twelve years
Dienocstrol B.P., Cream ..............................	Any disease or condition in a pensioner
Dienoestrol Tablets B.P. ..............................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Diethyl Dithiolisophthalate ..........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Diiodohydroxyquinoline B.P., Vaginal Tablet	Trichomonal and monilial vaginitis
Dihydrostreptomycin Sulphate Injection B.P..	As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Diloxanide Furoate ......................................	Amoebic dysentery
Diphenhydramine Hydrochloride B.P., Elixir.	Any disease or condition in a child under the age of twelve years
Disodium Diethylstilboestrol Diphosphate.....	Carcinoma of the prostate
Erythromycin B.P. .......................................

Erythromycin Tablets B.P. ...........................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins
Erythromycin Glucoheptonate......................
Erythromycin Propionate .............................

Fifth Schedule—continued.

  

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act.
Erythromycin B.P., Oral Sachet	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years
Erythromycin B.P., Oral Suspension
Erythromycin Stearate, Oral Suspension
Ethinylocstradiol Tablets B.P. .................	Turner's syndrome
Pre-menopausal castration syndrome
Any disease or condition in a pensioner
Ethionamide ...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ethisterone Tablets B.P. ..............................	Turner's syndrome
Habitual abortion
Any disease or condition in a pensioner
Ferric Hydroxide Colloidal Solution	Any disease or condition in a child under the age of twelve years
Ferrous Aminoacetosulphatc Syrup
Ferrous Gluconate Elixir .........................
Ferrous Succinate Syrup...............................
Fludrocortisone Acetate ...............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Fluoxymestorone ........................................	Mammary carcinoma
Folic Acid B.P. .......................................	Macrocytic anaemia
Folic Acid Tablets B.P. ...........................	Sprue or the sprue-like syndrome
Formyl-Tetrahydropteroyl Glutamic Acid	Any disease or condition in a patient receiving treatment in or at an approved hospital
Griseofulvin ................................................	With the written authority of the Director-General—
For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report:—
Epidermophyton floccosum
Microsporum audouni
Microsporum canis
Microsporum gypseum
Trychophyton interdigitale
Trichophyton mentagrophytes
Trichophyton rubram
Trichophyton schoenleini
Trichophyton sulphureum
Trichophyton verrucosum
Haemophilus Influenza Bacterial Serum	Any disease or condition in a pattern, receiving treatment in or at an approved hospital
Hexachlorophene, 3% with Entsufon
Hexachlorophene, 3% with Lissapol
Hexachlorophene, 1.5% with Soap Solution
Hydrocalciferol ...........................................	Parathyroid deficiency
Hydrocortisone Injection B.P. ......................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate B.P.	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydrocortisone Sodium Succinate Injection B.P.	Acute adrenal failure due to a medical or surgical crisis
Stevens-Johnson syndrome
Isionazid Tablets B.P. ..................................	Hansen's disease
Tuberculosis

Fifth Schedule—continued.

   

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be proscribed) for supply under Part VII. of the Act.
Kanamycin Sulphate ...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate B.P.C. ........................	Obstetrical use
Severe intractable pain
Lissapol Deodorant Detergent (Lissapol N100 with Spearmint Oil and Cetrimide)	Ileostomy or colostomy condition
Lofenalac ...................................................	With the written authority of the Director-General, phenylketonuria
Malt Extract B.P. ......................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Malt Extract with Cod Liver Oil B.P.
Mcpyramme Maleate Elixir .........................	Any disease or condition in a child under the age of twelve years
Mercaptopurine Tablets B.P. ........................	Allergic angiitis
Periarteritis
Systemic lupus erythematosus
The leukaemias
Mcthenolone Oenanthrate ............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin ..................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methyl Androstanolone ...............................	Mammary carcinoma
Methylandrostenediol ..................................	Senile osteoporosis proven by radiography
Methyl Prednisolone Acetate .......................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Minafen ......................................................	With the written authority of the Director-General, phenylketonuria
Morphine with Tacrine, 30mg.–15mg. Oral Tablet	Severe intractable pain
Mustine Injection B.P. .................................	Malignant lymphoma and related conditions
Nandrolone .................................................	Mammary carcinoma
Neomycin Sulphate B.P., in a form other than Eye Drops	Any disease or condition in a patient receiving treatment in or at anapproved hospital
Nicotinamide Tablets B.P. ...........................	Any disease or condition in a pensioner
Nicotinic Acid Tablets B.P. .........................	Any disease or Condition in a pensioner
Nitrofurantoin .............................................	Urinary tract infections
Nitrofurantoin Suspension ...........................	Any urinary tract infection in a child under the age of twelve years
Nitromin .....................................................	Malignant lymphoma and related conditions
Norethandrolone .........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Calcium B.P. .......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Sodium B.P. .........................
Novobiocin Tablets B.P. .........................
Nystatin ......................................................	Proven monilia infections
Oxytetracycline Tablets B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Injection B.P.
Oxytctracycline and Procaine Injection B.P.
Calcium Di-Oxytetracycline .....................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Oxytetracycline Paediatric Drops
Pancreatin B.P. .......................................	Fibrous disease of the pancreas
Pancreatin Enzyme 4, U.S.N.F. XI.	Pancreatico-duodenectomy
	Pancreatic steatorrhea

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to lite persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Para-Aminosalicylic Acid ............................	Tuberculosis
Paramethasone Acetate ................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion B.P. .....................	Any disease or condition in a pensioner
Pethidine and Levallorphan Tartrate .............	Obstetrical use
Phenoxymethylpenicillin B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension
Phenoxymethylpenicillin Calcium B.P., Oral Suspension
Phenoxymethylpemcillin (Hydrabamine Salt), Oral Suspension
Phenoxymethylpenicillin Potassium B.P., Oral Suspension
Benzylpenicillin B.P., with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Phenytoin Sodium B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phytomenadione Injection B.P. ....................	Antidote to anticoagulants
Piperazine Citrate B.P., Elixir ......................	Any disease or condition in a child under the age of twelve years
Polydimethylsiloxanes .................................	Ileostomy or colostomy conditions
Prednisolone Disodium Phosphate ................	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets B.P. ............................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Adrenogenital syndrome
Cranial arteritis
Cushing's syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative, associated with drug therapy
Dermatomyositis
Encephalomyelitis
Guillain—Barre syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen's disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkins disease
Idiopathic hypercalcaemia
Keratoplasty
The leukaemias
Lymphosarcoma and follicular lymphoma
Metastatic breast carcinoma
Nephritis, type II.
Nephrosis or nephrotic syndrome
Neuro-myelitis optica
Nodular non-suppurative panniculitis (Christian-Weber disease)
Optic neuritis following removal of tumour of the brain

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part. VII. of the Act.
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch's
Purpura, thrombocytopenic
Reticulum cell sarcoma
Rheumatic carditis, acute
Salaam convulsions and hypsarrythmia
Sarcoidosis
Sclerederma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropena and agranulocytosis
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens—Johnson syndrome
Still's disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Ulcerative colitis proven by sigmoidoscopy or radiological report
Uveitis, posterior
Methyl Prednisolone ............................	With the written authority of the Director General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Acetate B.P. ..............	With the written authority or the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone Sodium Hemisuccinate	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets B.P. .......................	With the written authority of the Director-General—
A disease or condition specified in this column in relation to Cortisone Injection
Nodular non-suppurative panniculitis (Christian-Weber disease)
Prednisone B.P. with Magnesium Trisilicato B.P. and Dried Aluminium Hydroxide Gel. B.P. .........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Progesterone Injection B.P. ..................	Habitual abortion
Promethazine Hydrochloride B.P., Elixir	Any disease or condition in a child under the age of twelve years
Prophenpyridamine Malcate, Oral Syrup	Any disease or condition in a child under the age of twelve years
Protoveratrines A ................................	Hypertensive crisis
Pyrazinamide ......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridine Aldoximc Mcthiodidc .............	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the poisons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Pyridostigmine Injection B.P. ...............	Myasthenia gravis
Pyridostigmine Tablets B.P. .................	Myasthenia gravis
Riboflavine Tablets B.P. ......................	Any disease or condition in a pensioner
Ristocetin ............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Salicylazosulphapyridine .....................	Ulcerative colitis
Senna Fruit Extract ..............................	Any disease or condition in a pensioner
Sobee ..................................................	With the written authority of the Director-General, galactosaemia
Sodium Aminosalicylate B.P.	Tuberculosis
Sodium Aminosalicylate Tablets B.P.
Sodium Folate .....................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin .........................................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins
Spironolactone ....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Stilboestrol B.P. ..................................	Carcinoma of the prostate
Stilboestrol Tablets B.P. .......................	Mammary carcinoma
Any disease or condition in a pensioner
Streptomycin Sulphate B.P. ..................	Bacillary dysentary that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyaneus infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Streptomycin Sulphate Injection B.P. ....	A disease or condition specified in this column in relation to Streptomycin Sulphate
Streptomycin Sulphate B.P. with Benzyl-penicillin Sodium. B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Sulphadimethoxine Suspension
Sulphadimidine Oral Suspension	Any disease or condition in a child under the age of twelve years
Sulphaphenazole Syrup ...................
Surgical cement ...................................	Ileostomy or colostomy conditions
Sustanon .......................................
Testosterone Implants B.P. .............	Castration syndrome
Testosterone Oenanthate ......................	Mammary carcinoma
Testosterone Propionate Injection B.P.	Castration syndrome
Testosterone Propionate B.P.	Kline felter Rcifenstein Albright syndrome
Mcthyltestosterone Tablets B.P.	Mammary carcinoma
Tetracycline with a buffering agent and Amphotericin B	A disease or condition specified in this column in relation to Tetracycline with Nystatin in a child under the age of twelve years

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Tetracycline Capsules B.P. ................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets B.P. ..................
Tetracycline and Procaine Injections B.P.
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules
Tetracycline Injection B.P. ..
Tetracycline with Oleandomycin Capsules
Pyrrolidino-Methyl-Tetracycline
Tetracycline with a buffering agent— Oral Suspension	A disease or condition, specified in this column in relation to Chloretracycline capsules, in a child under the age of twelve years
Tetracycline with a buffering agent— Paediatric Drops
Tetracycline with Oleandomycin—Oral Suspension
Tetracycline with Oleandomycin —Paediatric Drops
Tetracycline with Nystatin ......................	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Thcnalidine Tartrate Syrup ......................	Any disease or condition in a child under the age of twelve years
Thyrotropin ............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tragacanth B.P., Powder .........................	Ileostomy or colostomy conditions
Triamcinolone ........................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Triethylcne Thiosphosphoramide .............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine ..............................................	Malignant lymphoma and related conditions
Trifluoperazine .......................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride or Trifluoperazine
Trimetaphan Camphorsulphonate ............	Hypotensive for anaesthesia
Triprolidine Hydrochloride, Elixir ...........	Any disease or condition in a child under the age of twelve years
Vancomycin Hydrochloride ....................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued.

Pharmaceutical Benefit. Purpose for which, andthe Conditions subject to which, the Pharmaceutical Benefit may be prescribed (Including any restrictions asto the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.

Veriloid .................................................	Hypertensive crisis
Viomycin Sulphate .................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D	Any disease or condition in a pensioner
Vitamin A Oral Tablets ...........................	Any disease or condition in a pensioner
Concentrated Vitamin A Solution B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin A and D Solution B.P.
Concentrated Vitamin D Solution B.P.	Tetany
Any disease or condition in a child under the age of twelve years or in a pensioner
Vitamin K ..............................................	As an antidote to anticoagulants

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.